Startseite Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6
Artikel Open Access

Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6

  • Hao Zhu , Ying-Ying Guo , Shan Liu , Yi-Fan Li , Han-Yang Lan , Peng-Yu Zhuang und Qi-Di Zhong EMAIL logo
Veröffentlicht/Copyright: 8. Februar 2018

Abstract

C42H42N2O6, monoclinic, P21/c (no. 14), a = 6.9848(14) Å, b = 20.816(4) Å, c = 11.543(2) Å, β = 99.745(5)°, V = 1654.1(6) Å3, Z = 2, Rgt(F) = 0.0377, wRref(F2) = 0.1019, T = 113(2) K.

CCDC no.: 1535101

The centrosymmetric cage dimeric title structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless prism
Size:0.20 × 0.18 × 0.12 mm
Wavelength:Mo radiation (0.71073 Å)
μ:0.9 cm−1
Diffractometer, scan mode:Rigaku XtaLAB P200, φ and ω
2θmax, completeness:55°, >99.6%
N(hkl)measured, N(hkl)unique, Rint:16568, 3779, 0.0352
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3129
N(param)refined:228
Programs:Rigaku [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O1−0.27129(13)0.55565(5)0.95362(8)0.0195(2)
O20.44732(12)0.39885(4)0.42556(8)0.0192(2)
O30.22737(12)0.33065(4)0.47684(8)0.0185(2)
N1−0.08299(13)0.44852(5)0.62036(8)0.0123(2)
C10.11432(16)0.44996(6)0.59723(10)0.0121(2)
H10.20300.42170.65220.015*
C20.13796(16)0.43926(6)0.46339(10)0.0118(2)
C30.21163(16)0.50990(6)0.45941(10)0.0120(2)
H30.34900.51210.44560.014*
C40.19616(16)0.51902(6)0.59185(10)0.0124(2)
H40.32710.52340.64190.015*
C50.05948(16)0.57366(6)0.61423(10)0.0121(2)
H50.11190.61430.58560.015*
C60.05427(17)0.58228(6)0.74456(10)0.0131(2)
C7−0.10626(17)0.56572(6)0.79516(10)0.0142(2)
H7−0.21960.54940.74700.017*
C8−0.10255(17)0.57283(6)0.91574(11)0.0155(2)
C90.06284(18)0.59590(6)0.98779(11)0.0186(3)
H90.06680.60021.07010.022*
C100.22239(18)0.61260(7)0.93666(11)0.0198(3)
H100.33580.62870.98500.024*
C110.22006(18)0.60635(6)0.81700(11)0.0169(3)
H110.33060.61840.78410.020*
C12−0.2689(2)0.55604(7)1.07762(11)0.0217(3)
H12A−0.16430.52811.11620.033*
H12B−0.39380.54041.09420.033*
H12C−0.24690.59991.10760.033*
C13−0.15685(17)0.39275(6)0.66632(10)0.0131(2)
C14−0.33332(17)0.39502(6)0.70993(10)0.0152(2)
H14−0.40560.43390.70520.018*
C15−0.40215(18)0.34088(6)0.75966(11)0.0184(3)
H15−0.52270.34300.78720.022*
C16−0.2986(2)0.28370(7)0.77002(12)0.0221(3)
H16−0.34610.24710.80540.027*
C17−0.1241(2)0.28105(7)0.72769(12)0.0233(3)
H17−0.05130.24230.73420.028*
C18−0.05509(18)0.33461(6)0.67579(11)0.0183(3)
H180.06350.33170.64620.022*
C190.28929(16)0.38898(6)0.45105(10)0.0133(2)
C200.36169(19)0.27741(6)0.47523(12)0.0217(3)
H20A0.49450.29030.51210.026*
H20B0.36450.26370.39340.026*
C210.2896(2)0.22368(7)0.54347(15)0.0309(3)
H21A0.29150.23740.62480.046*
H21B0.37380.18610.54250.046*
H21C0.15650.21250.50750.046*

Source of material

The title compound was synthesized by ethyl 1-phenyl-1,4-dihydro-4-(3-methoxyphenyl)pyridine-3-carboxylate under irradiation of UV-light in methanol/THF solution. After approximately 48 h irradiation was stopped and the product was purified by TL chromatography using ethyl acetate-petroleum ether (1:30 v/v). After concentration in vacuum, colorless solids were collected, dried, and recrystallized from methanol. Colorless crystals were obtained 3 days later.

Experimental details

All H atoms were placed in idealized positions (C—H = 0.95-1.00 Å) and refined as riding atoms. The Uiso values were set to be 1.5Ueq of the carrier atom for nitrogen H atoms and 1.2Ueq for the remaining H atoms. The hydrogen atoms attached to carbon were placed on calculated positions with the help of the SHELX program (AFIX 23, 43 or 137 option) [2].

Discussion

The title compound is a derivative of 3,9-diazatetraasteranes and plays important roles in synthetic, therapeutic, and bioorganic chemistry, for example, it shows anti-HIV PR activity [3]. As competitive inhibitors [4], 3,9-diazatetraasteranes are among the most promising classes of novel inhibitors of HIV-1 PR. In general, they have unique caged structures as well as lipophilic properties [5]. Furthermore, cage dimeric HIV-1 PR inhibitors have been introduced as novel lead structures [6]. Only a small number of 3,9-diazatetraasteranes have been reported so far [7]. In order to search for new 3,9-diazatetraasteranes, the title compound was synthesized and its crystal structure was determined.

The molecular structure of the title compound is shown in the figure. It displays exact centrosymmetry. The substitution at the central cage is such that at the C2—C5a—C4a joint of the piperidine rings there is one bulky substituent at C2 and C5a, while at the C3—N1a—C1a joint there is only one non-H substituent. Apart from this group, the N1a atom bears no other substituent, not even a hydrogen atom. This generates much more crowding at C4 and C2 of the cyclobutane ring than at C3 and C1. Because of the Csp2 nature of the substituent at C5a, the orientation of the phenyl ring around the C5a—C6a bond is characterized by the following torsion angles: C4a—C5a—C6a—C7: 108.93°, C2—C5a—C6a—C7: −13.91°. The C2—C5a—C4a prow is inclined at very similar angles to the bottoms of both piperidinyl moieities (134.7° and 135.7°). The corresponding C—C5a distances are 1.535(2) Å, and the C2—C5a—C4a angle is 107.14(9)°. At the same time, the piperidinyl C—C—C5a valence angles are all very similar (113.0(2)−113.7(1)°, average 113.3° and correspond very well to the substituent angles in planar cyclobutane rings (113.1(6)°) calculated by Allen [8]. All bond lengths and angles are within normal ranges [9].

Acknowledgements

This work was financially supported by the Key Projects in the Hebei Youth Natural Science Foundation (No. H2014209241).

References

Rigaku: RAPID-AUTO. Rigaku Corporation, Tokyo, Japan (1998).Suche in Google Scholar

Sheldrick, G. M.: Crystal structure refinement with SHELX. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar

Hilgeroth, A.; Tykarska, E.; Jaskolski, M.: Crystal structure of a novel synthetic inhibitor of HIV-1 protease. J. Mol. Struct. 605 (2002) 63–70.10.1016/S0022-2860(01)00751-7Suche in Google Scholar

Wollmann, J.; Baumert, C.; Erlenkamp, G.; Sippl, W.; Hilgeroth, A.: Novel insight into inhibitor binding of highly symmetric HIV-1 protease. ChemBioChem 9 (2008) 874–878.10.1002/cbic.200700646Suche in Google Scholar PubMed

Hilgeroth, A.; Fleischer, R.; Wiese, M.; Heinemann, F. W.: Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cage dimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representative of a novel class of HIV-1 protease inhibitors: A molecular modeling study. J. Comput. Aid. Mol. Des. 13 (1999) 233–242.10.1023/A:1008038608460Suche in Google Scholar

Wlodawer, A.; Vondrasek, J.: Crystal structure of a novel synthetic inhibitor of HIV-1 protease. Ann. Rev. Biophys. Biomol. struct. 27 (1998) 249–284.10.1146/annurev.biophys.27.1.249Suche in Google Scholar PubMed

Hilgeroth, A.; Billich, A.: Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors. Cheminform. 332 (1999) 3–5.10.1002/(SICI)1521-4184(19991)332:1<3::AID-ARDP3>3.0.CO;2-1Suche in Google Scholar

Allen, F. H.: The geometry of small rings. VI. Geometry and bonding in cyclobutane and cyclobutene. Acta Crystallogr. 40 (1984) 64–72.10.1107/S0108768184001750Suche in Google Scholar

Allen, F. H.; Kennard, O.; Watson, D. G.; Brammer, L.; Orpen, A. G.; Taylor, R.: Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds. Perkin Trans. 2. 2 (1987) S1–S19.10.1039/p298700000s1Suche in Google Scholar

Received: 2017-10-28
Accepted: 2018-1-23
Published Online: 2018-2-8
Published in Print: 2018-3-28

©2018 Hao Zhu et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Cover and Frontmatter
  2. Crystal structure and optical properties of diaqua-tris(nitrato-κ2O,O′)-bis(4,4,5,5-tetramethyl-2-(p-pyridyl)imidazoline-1-oxyl 3-oxide-κN)praseodymium(III), C24H36N9O15Pr
  3. Crystal structure of dimethanol-bis(μ2-methanol-κ2O:O)-bis{3-((4-methoxy-2-oxidobenzylidene)amino)-2-oxo-2H-chromen-4-olato-κ3O,N,O′}dimanganese(II), C38H38Mn2N2O14
  4. Crystal structure of catena-poly[diaqua-bis(μ2-2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ3O,O′:O′)calcium(II)], C56H48N4Ca2Cl8O12
  5. Crystal structure of catena-poly[triaqua-(isophthalato-κO)-(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)]nickel(II), C20H28N4NiO7
  6. Crystal structure of cyclo[hexaqua-bis[1-[(2-ethyl-1H-imidazol-1-yl) methyl]-1H-benzotriazole-κ2N:N′]-bis(sulfato-κ1O)dicadmium(II)] monohydrate, C24H42Cd2N10O16S2
  7. Crystal Structure of bis(2-fluorbenzoato-κO)-bis(1,10-phenanthroline-κ2N,N′)manganese(II) dihydrate, C38H28F2MnN4O6
  8. Crystal structure of tetrapropylammonium 5-hydroxyisophthalate tetrahydrate, C20H41NO9
  9. Crystal structural of 2-amino-4-(3-bromophenyl)-3-cyano-7,7-dimethyl-5-oxo-4H-5,6,7,8-tetrahydrobenzo[b]pyran, C18H17BrN2O2
  10. Crystal structural of 2-amino-4-(4-methoxyphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H16N2O3
  11. Crystal structure of catena-poly[aqua(μ2-1,3-bis(1H-benzo[d]imidazol-1-yl)propane-κ2N:N′)-(μ2-5-(tert-butyl)isophthalate-κ3O,O′:O′′)nickel(II)], C29H30N4NiO5
  12. Crystal structure of catena-poly[(μ2-dicyanamido-κ2N:N′)-(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O′)copper(II)], C9H8CuN4O
  13. Crystal structure of bis(5,5′-((butane-1,4-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido-k4N,N′,N′′,N′′′)copper(II), C24H32CuN4O4
  14. The crystal structure of the formamide solvate of (17b)-estra-1,3,5(10)-triene-3,17diol, C19H27NO3
  15. Crystal structure of catena-poly[diaqua-bis(μ2-1H-benzo[d]imidazole-5-carboxylato-κ2N:O)nickel(II)] dihydrate, C16H18N4NiO8
  16. Crystal structure of dibromido[(1,2-bis(diisopropylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]nickel(II), C14H38B10NiBr2P2
  17. The crystal structure of catena-poly[aquachlorido(3,3′-([4,4′-bipyridine]-1,1′-diium-1,1′-diylbis(methylene))dibenzoato-κ2O:O′)copper(II)] chloride dihydrate, C26H26Cl2CuN2O7
  18. The crystal structure of N′-(2-nitrobenzylidene)-2-phenylacetohydrazide, C15H13N3O3
  19. Crystal structure of dichlorido bis[1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole-κ1N]cadmium(II), C30H26CdCl2N10
  20. Crystal structure of aqua-bis(3-(2-pyridyl)-5-(4-pyridyl)-1H-1,2,4-triazole-κ2N,N′)copper(II) sulfate tetrahydrate, C24H28CuN10O9S
  21. Crystal structure of dibromido-carbonyl-(η6-p-cymene)osmium(II), C11H14Br2OOs
  22. Crystal structure of catena-poly[chlorido-(μ2-chlorido)-bis(imidazole-κN)copper(II)] C6H8Cl2CuN4
  23. Crystal structure of [(1,2-bis(dicyclohexylphosphino)-1,2-dicarba-closo-dodecaborane-κ2P,P′]dibromidonickel(II)), C26H54B10NiBr2P2
  24. Crystal structure of dichlorido[1,1′-bis(diphenylphosphanyl)ferrocene-κ2P,P′]zinc(II), C34H28FeCl2P2Zn
  25. Crystal structure of tris(μ2-2-(pyridin-2-yl)ethan-1-olato-κ3N,O:O)-trithiocyanato-κN-dicobalt(III), C24H24Co2N6O3S3
  26. The crystal structure of diaqua-2,2′-((cyclohexane-1,2-diylbis(azanylylidene))bis(methanylylidene))diphenolato-κ4N,N′,O,O′)manganese(III) perchlorate, C20H24MnClN2O4
  27. Crystal structure of bis(μ3-chlorido)-bis(μ2-chlorido)-tetrakis(μ2-2,6-bis (diphenylmethyl)-4-t-butylphenolato)tetralithium(I)dicobalt(II) toluene solvate, C75.5H70Cl2CoLi2O2
  28. The crystal structure of hexaaqua-bis(μ2-3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κ2O:O′)-tetrakis(3-(3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl)propanoato-κO)dierbium(III) octahydrate, C60H76N18O32Er2
  29. Crystal structure of dimethylammonium bis(naphthalene-2,3-diolato)borate, C22H20BNO4
  30. Crystal structure of 2-amino-4-(4-nitro-phenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H17N3O4
  31. The crystal structure of (E)-4-chloro-2-(((5-methylpyridin-2-yl)imino)methyl)phenol, C13H11ClN2O
  32. Crystal structure of bis(N,N,N-trimethylbutanaminium) poly[heptaselenidotristannate(IV)], C14H36N2Se7Sn3
  33. The crystal structure of N-((3,5-di-tert-butyl-4-hydroxyphenyl)(phenyl)methyl)-4-methylbenzenesulfonamide, C28H35N3S
  34. Crystal structure of 2-(4-chlorophenyl)-2,3-dihydro-1H-perimidine, C17H13Cl1N2
  35. The Crystal structure of 2-iodo-1-(p-tolyl)propan-1-one, C10H11IO
  36. Crystal structure of ethyl 1-(4-bromobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17BrN2O2
  37. Crystal structure of ethyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C19H17FN2O2
  38. Crystal structure of catena-poly[diaqua-(μ2-2,5-dihydroxyterephthalato-κ4O,O′:O′′,O′′′)cadmium(II)], C8H8O8Cd
  39. Crystal structure of tetraaqua-bis[6-(1H-imidazol-1-yl-κN)nicotinato]zinc(II), C18H20N6O8Zn
  40. Crystal structure of dichlorido-bis(N-phenyl-2-(quinolin-8-yloxy)acetamide-κ2N,O) – acetone (2/1), C35.5H31N4O4.5Cl2Cu
  41. Crystal Structure of ethyl (E)-3,4-dimethyl-5-((2-(4-methylbenzoyl)hydrazono)methyl)-1H-pyrrole-2-carboxylate — water — ethanol (1/1/1), C20H29N3O5
  42. Crystal structure of 5-((4-(1H-benzo[d]imidazol-2-yl)-2-methoxyphenoxy)methyl)-2-chlorothiazole - trichloromethane - methanol (1/1/1), C20H19Cl4N3O3S
  43. The crystal structure of a matrine derivative: 41S,7aS,12S,13aR,13bR)-12-(4-methylpiperazin-1-yl)dodecahydro-1H,5H,10H-dipyrido[2,1-f:3′,2′,1′-ij][1,6]naphthyridin-10-one, C20H34N4O
  44. Crystal structure of cesium beryllophosphate, Be3Cs2P4O14
  45. Crystal Structure of 3-((3-hydroxybenzyl)ammonio)-3-phenylpropanoate, C16H17NO3
  46. Crystal structure of 9,10-dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride — 4-hydroxy-3-methoxybenzoic acid — water (2/1/5), C48H54N2Cl2O17
  47. The crystal structure of (1R, 2R)-N1,N2-diferrocenyl-1,2-cyclohexanedicarboxamide, C28H30Fe2N2O2
  48. Crystal structure of N-(2-methylphenyl)ethoxycarbothioamide, C10H13NOS
  49. Crystal Structure of ethyl (E)-2,4-dimethyl-5-((2-tosylhydrazono)methyl)-1H-pyrrole-3-carboxylate monohydrate, C17H23N3O5
  50. Crystal structure of Diiodo-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3N,N′,O)cadium(II) – dimethylformamide (1/1), C19H19N5O2CdI2
  51. Crystal structure of dinitrato-(N′-((quinolin-8-yl)methylene)isonicotinohydrazide κ3-N,N′,O)copper(II), C16H12N6O7Cu
  52. Crystal structure of benzoato-κO-bis(1,3,5-triaza-7-phosphaadamantane-κP)silver(I) monohydrate C19H31AgN6O3P2
  53. Crystal structure of (E)-2-(anthracen-9-ylmethylene)hydrazine-1-carbothioamide, C16H13N3S
  54. The crystal structure of 8-chloro-7-ethyl-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, C9H11ClN4O2
  55. Crystal structure of {5,5′-((propane-1,3-diylbis(azanylylidene))bis(methanylylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′}zinc(II), C23H30N4O4Cu
  56. Crystal structure of bis(4-dimethylamino-pyridin-1-ium)tetrafluorosuccinate, C18H22F4N4O4
  57. Crystal structure of dimethyl 3,9-dibenzyl-6,12-dicyclohexyl-3,9-diazahexacyclo [6.4.0.02,7.04,11.05,10]-dodecane-1,11-dicarboxylate, C40H50N2O4
  58. Crystal structure of diethyl 3,9-diphenyl-6,12-bis(3-methoxyphenyl)-3,9-diazahexacyclo[6.4.0.02,7.04,11.05,10]dodecane-1,11-dicarboxylate, C42H42N2O6
  59. Crystal structure of bis(acetato-κO)-bis(1-(pyridin-2-yl)ethan-1-one oxime-κ2N,N′)nickel(II), C18H22N4NiO6
  60. Crystal structure of (N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3N,O,O′)-diphenyltin(IV), C28H23FN2O3Sn
  61. Crystal structure of {N-(3-ethoxy-2-oxidobenzylidene)-4-fluorobenzohydrazonato-κ3O,N,O′}dimethyltin(IV), C18H19FN2O3Sn
Heruntergeladen am 6.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0333/html?licenseType=open-access
Button zum nach oben scrollen